This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) slipped 1.23% to $106.40 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.70% to 4,357.73 and Dow Jones Industrial Average falling 1.78% to 33,970.47. This was the stock's second consecutive day of losses. AbbVie Inc. closed $15.13 short of its 52-week high ($121.53), which the company achieved on September 1st.
The stock underperformed when compared to some of its competitors Monday, as Pfizer Inc. (PFE) rose 0.71% to $44.20, Eli Lilly & Co. (LLY) rose 0.67% to $231.64, and AstraZeneca PLC ADR (AZN.LN) rose 5.29% to $58.50. Trading volume (6.9 M) remained 262,591 below its 50-day average volume of 7.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 20, 2021.
(END) Dow Jones Newswires
September 20, 2021 16:33 ET (20:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.